Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

cbdMD (YCBD) EBITDA Margin (2016 - 2025)

Historic EBITDA Margin for cbdMD (YCBD) over the last 10 years, with Q3 2025 value amounting to 14.53%.

  • cbdMD's EBITDA Margin fell 75800.0% to 14.53% in Q3 2025 from the same period last year, while for Sep 2025 it was 11.27%, marking a year-over-year increase of 53700.0%. This contributed to the annual value of 11.27% for FY2025, which is 53700.0% up from last year.
  • cbdMD's EBITDA Margin amounted to 14.53% in Q3 2025, which was down 75800.0% from 19.64% recorded in Q2 2025.
  • cbdMD's 5-year EBITDA Margin high stood at 1.69% for Q4 2024, and its period low was 373.55% during Q2 2022.
  • For the 5-year period, cbdMD's EBITDA Margin averaged around 79.4%, with its median value being 32.2% (2024).
  • Per our database at Business Quant, cbdMD's EBITDA Margin crashed by -3147500bps in 2022 and then surged by 3453300bps in 2023.
  • Quarter analysis of 5 years shows cbdMD's EBITDA Margin stood at 255.1% in 2021, then skyrocketed by 75bps to 64.84% in 2022, then surged by 69bps to 19.83% in 2023, then soared by 91bps to 1.69% in 2024, then crashed by -761bps to 14.53% in 2025.
  • Its EBITDA Margin was 14.53% in Q3 2025, compared to 19.64% in Q2 2025 and 10.23% in Q1 2025.